Merck Sharp & Dohme Corp. (Intervet Inc. d/b/a Merck Animal Health), 2026-05-15: FDA-approved over-the-counter label for Panacur C granules, the product Tippens named. It states 22.2% fenbendazole (222 mg/g), a daily dose of 50 mg/kg for three consecutive days, 1 g, 2 g and 4 g packets, and vomiting in about 1% of 240 dogs in US clinical studies.
In US clinical studies 3 of 240 dogs (about 1% of the treated dogs) had vomiting associated with use of the product.
Merck Sharp & Dohme Corp. (Intervet Inc. d/b/a Merck Animal Health), 2026-05-15: FDA-approved over-the-counter label for Panacur C granules, the product Tippens named. It states 22.2% fenbendazole (222 mg/g), a daily dose of 50 mg/kg for three consecutive days, 1 g, 2 g and 4 g packets, and vomiting in about 1% of 240 dogs in US clinical studies. Product label, not a study. The label's own adverse-reaction figure comes from US clinical studies in 240 dogs. The Drug Facts panel for this animal product lists the active ingredient only and does not print an inactive-ingredient list; the professional insert describes the granules as fenbendazole 222 mg/g with the balance being the granule carrier, without naming excipients. Package sizes 3 x 1 g, 3 x 2 g and 3 x 4 g. Manufacturer: Intervet GesmbH, Vienna, Austria; distributed by Intervet Inc. d/b/a Merck Animal Health. Label revision 07/22. This is the product most often used by people who take fenbendazole themselves, and the label is written for dogs only. Also filed as FBA-34, FBB-36 (claims C6, C7). Study type: regulatory record.
